In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds (2014)
- Authors:
- USP affiliated authors: LEOPOLDINO, ANDRÉIA MACHADO - FCFRP ; SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.2174/18779468113036660018
- Subjects: MODELAGEM MOLECULAR; FÁRMACOS (PLANEJAMENTO); PROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Physical Chemistry
- ISSN: 1877-9476
- Volume/Número/Paginação/Ano: v. 4, n. 1, p. 30-34, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Vinícius Barreto da e LEOPOLDINO, Andréia Machado e SILVA, Carlos Henrique Tomich de Paula da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds. Current Physical Chemistry, v. 4, n. 1, p. 30-34, 2014Tradução . . Disponível em: https://doi.org/10.2174/18779468113036660018. Acesso em: 05 fev. 2026. -
APA
Silva, V. B. da, Leopoldino, A. M., & Silva, C. H. T. de P. da. (2014). In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds. Current Physical Chemistry, 4( 1), 30-34. doi:10.2174/18779468113036660018 -
NLM
Silva VB da, Leopoldino AM, Silva CHT de P da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 30-34.[citado 2026 fev. 05 ] Available from: https://doi.org/10.2174/18779468113036660018 -
Vancouver
Silva VB da, Leopoldino AM, Silva CHT de P da. In silico bioisosteric replacements of hnRNP K ligands as anticancer lead compounds [Internet]. Current Physical Chemistry. 2014 ; 4( 1): 30-34.[citado 2026 fev. 05 ] Available from: https://doi.org/10.2174/18779468113036660018 - Identification of potential ligand binding sites and virtual screening of ligands for ZRF1 biomarker in cancer therapy
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
- Current topics in computer-aided drug design
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- General aspects of lead finding and optimization in drug discovery
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
Informações sobre o DOI: 10.2174/18779468113036660018 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
